Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

HKPD

Cellyan Biotechnology Co., Ltd

CIK 0002007702 · Nasdaq

NasdaqHealth CareWholesale-Drugs, Proprietaries & Druggists' Sundries
$0.41
↓ 0.00 (-0.07%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$6.68M
P/E Ratio
-246.98
EPS
-0.00
Dividend Yield
Not covered
52W Position
4%
Beta
0.88

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.30
P/S
0.33
EV/Revenue
0.40
ROE
-0.5%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 4%
$0.31$2.58

Latest Financials

2025-03-31 FY
Revenue
$20.31M
Net Income
-$27.06K
Total Assets
$9.42M
Free Cash Flow
$499.30K

Recent news